𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antifibrotic effects of an sGC activator in rat models of liver fibrosis

✍ Scribed by Claudia Hirth-Dietrich; Cristina Alonso-Alija; Michael Härter; Michael G Hahn; Yvonne Keim; Frank Wunder; Andreas Knorr; Johannes-Peter Stasch


Publisher
BioMed Central
Year
2005
Tongue
English
Weight
188 KB
Volume
5
Category
Article
ISSN
1471-2210

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Antifibrotic effects of a tissue inhibit
✍ Christopher J. Parsons; Blair U. Bradford; Clark Q. Pan; Ellen Cheung; Michael S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB 👁 1 views

Liver fibrosis is characterized by increased synthesis, and decreased degradation, of extracellular matrix (ECM) within the injured tissue. Decreased ECM degradation results, in part, from increased expression of tissue inhibitor of metalloproteinase-1 (TIMP-1), which blocks matrix metalloproteinase

Effect of antifibrotic agent silymarin o
✍ Gabriele Boigk; Hermann Herbst; Ji-Dong Jia; Ernst Otto Riecken; Detlef Schuppan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

Silymarin (SIL), a standardized plant extract containing about 60% of the polyphenol silibinin, is used as a hepatoprotective agent. In order to explore the effect of SIL on liver cell regeneration in a model of progressive biliary liver fibrosis this substance was applied to adult Wistar rats that

Antifibrotic effect of captopril and ena
✍ Mahmoud Ghazi-Khansari; Ali Mohammadi-Karakani; Masoud Sotoudeh; Parvin Mokhtary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract Although different treatment modalities have been implemented for pulmonary fibrosis, the results have not been promising and these conditions have been considered untreatable and irreversible. Thus, a plethora of new drugs has been tried for the control of this condition in recent year